Government Designates 8 New Essential Medicines to Ensure Stable Patient Supply
Published
The government announced that it has newly designated eight essential medicines as national essential drugs. This measure aims to ensure that medicines that are truly necessary are stably supplied to patients.
The medicines designated this time are essential for severely ill newborns, patients with rare diseases, cancer patients, and others. Because these patients must continue to receive specific medicines for their treatment, a shortage of these drugs could have a significant impact on their care.
National essential medicines refer to medicines that are specially managed so that their supply is not interrupted. Through this designation, the government intends to prevent shortages of necessary medicines before they occur.
The purpose of this measure is to enable severely ill patients, patients with rare diseases, and cancer patients to continue receiving the treatment they need. Attention should be paid to whether these medicines are actually supplied stably going forward.
Sources: 코리아헬스로그
More South Korea news
- Digital TVET master's program launches in South Korea
- Gyeongbuk health group donates 100 boxes of grapes to children
- US Big Tech Pursues Multi-Trillion Won Investments in South Korean Data Centers Amid Uncertainty
- KB Insurance to Hold Open Recruitment for New Employees in Second Half of 2026
- Kolmar Korea Wins CES Beauty Tech Best Innovation Award for Second Straight Year, Setting World First
- China Closes In on Korea's Core LNG Carrier Market, Expanding from Mega-Vessels to Equipment
- China's Rapid Technological Development: South Korea Must Change Its Regulations and Labor System
- Ambassador Michelle Steel: American Companies Operating in Korea Should Compete in a Fair Environment